MsD reltec

Like MD21, MsD is a medical device for professionals in Japan. Therefore, medical insurance is available for therapy with MD21 in Japan. Indications in Japan include headaches, stiff shoulders, insomnia, and chronic constipation.

MsD is a RE therapeutic device for people who want to treat diseases but have difficulty devoting themselves to therapy, such as those with busy work schedules. MsD was developed with the premise of seated therapy, therapy in fragmented periods, and therapy by carrying the RE therapeutic device to various locations.

RE therapeutic devices use microcurrent to supply electrons to the human body for antioxidation. MsD’s microcurrent current value (therapeutic current value) per output channel is higher than that of any other RE therapeutic device.

The reasons why we set a high treatment current value for MsD are as follows.

1. We wanted to increase the effectiveness of therapy in fragment periods and seated therapy.
2. Based on our past research¹, we aim to set a therapeutic current value that effectively improves lymphocyte immunity.